Connection

Patrick O'Neil to Female

Back to Details
This is a "connection" page, showing publications Patrick O'Neil has written about Female.
Patrick O'Neil
Connection Strength
0.692
Female
  1. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
    View in: PubMed
    Score: 0.037
  2. Evaluation of a Lifestyle Change Worksite Weight Management Program Across Multiple Employers and Sites. J Occup Environ Med. 2018 12; 60(12):1112-1115.
    View in: PubMed
    Score: 0.034
  3. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.
    View in: PubMed
    Score: 0.033
  4. Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention. Obesity (Silver Spring). 2017 12; 25(12):2062-2067.
    View in: PubMed
    Score: 0.032
  5. Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials. Diabetes Obes Metab. 2017 11; 19(11):1529-1536.
    View in: PubMed
    Score: 0.031
  6. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
    View in: PubMed
    Score: 0.030
  7. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
    View in: PubMed
    Score: 0.030
  8. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
    View in: PubMed
    Score: 0.029
  9. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS. Endocr Pract. 2016 11; 22(11):1277-1287.
    View in: PubMed
    Score: 0.029
  10. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
    View in: PubMed
    Score: 0.024
  11. Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
    View in: PubMed
    Score: 0.024
  12. Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eat Behav. 2012 Dec; 13(4):354-60.
    View in: PubMed
    Score: 0.022
  13. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012 Jul; 20(7):1426-36.
    View in: PubMed
    Score: 0.021
  14. Socially desirable responding by bariatric surgery candidates during psychological assessment. Surg Obes Relat Dis. 2013 Mar-Apr; 9(2):300-5.
    View in: PubMed
    Score: 0.020
  15. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond). 2009 Jan; 33(1):144-50.
    View in: PubMed
    Score: 0.017
  16. Editorial: lessons from, and on, the psychological assessment of bariatric surgery patients. Surg Obes Relat Dis. 2006 Mar-Apr; 2(2):133-5.
    View in: PubMed
    Score: 0.014
  17. Utility and validity of the eating behavior inventory in clinical obesity research: a review of the literature. Obes Rev. 2005 Aug; 6(3):209-16.
    View in: PubMed
    Score: 0.014
  18. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol. 2004 Mar; 9(1):59-65.
    View in: PubMed
    Score: 0.012
  19. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res. 2002 Jul; 10(7):633-41.
    View in: PubMed
    Score: 0.011
  20. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.
    View in: PubMed
    Score: 0.011
  21. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 04 13; 325(14):1403-1413.
    View in: PubMed
    Score: 0.010
  22. Which comes first in the pathogenesis of bulimia nervosa: dieting or bingeing? Int J Eat Disord. 2000 Nov; 28(3):259-64.
    View in: PubMed
    Score: 0.010
  23. The perceived relative worth of reaching and maintaining goal weight. Int J Obes Relat Metab Disord. 2000 Aug; 24(8):1069-76.
    View in: PubMed
    Score: 0.010
  24. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 08 08; 381(6):520-530.
    View in: PubMed
    Score: 0.009
  25. Description, utilisation and results from a telehealth primary care weight management intervention for adults with obesity in South Carolina. J Telemed Telecare. 2020 Jan-Feb; 26(1-2):28-35.
    View in: PubMed
    Score: 0.008
  26. The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
    View in: PubMed
    Score: 0.008
  27. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care. 2018 08; 41(8):1590-1599.
    View in: PubMed
    Score: 0.008
  28. Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study. Obesity (Silver Spring). 2018 01; 26(1):61-69.
    View in: PubMed
    Score: 0.008
  29. The National Women's Study: relationship of victimization and posttraumatic stress disorder to bulimia nervosa. Int J Eat Disord. 1997 Apr; 21(3):213-28.
    View in: PubMed
    Score: 0.008
  30. Effects of body fat distribution on body size estimation accuracy among obese women. Int J Obes Relat Metab Disord. 1997 Mar; 21(3):250-3.
    View in: PubMed
    Score: 0.008
  31. Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.
    View in: PubMed
    Score: 0.007
  32. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016 09; 40(9):1369-75.
    View in: PubMed
    Score: 0.007
  33. The number of divergent purging behaviors is associated with histories of trauma, PTSD, and comorbidity in a national sample of women. Eat Disord. 2015; 23(5):422-9.
    View in: PubMed
    Score: 0.007
  34. Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes. Obesity (Silver Spring). 2014 Oct; 22(10):2137-46.
    View in: PubMed
    Score: 0.006
  35. A comparison of women with child-adolescent versus adult onset binge eating: results from the National Women's Study. Int J Eat Disord. 2014 Nov; 47(7):836-43.
    View in: PubMed
    Score: 0.006
  36. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013 Nov; 21(11):2189-2196.
    View in: PubMed
    Score: 0.006
  37. Factors associated with development of excessive fatness in children and adolescents: a review of prospective studies. Obes Rev. 2013 Aug; 14(8):645-58.
    View in: PubMed
    Score: 0.006
  38. The Food Craving Questionnaire-Trait in a bariatric surgery seeking population and ability to predict post-surgery weight loss at six months. Eat Behav. 2012 Dec; 13(4):366-70.
    View in: PubMed
    Score: 0.005
  39. Prefrontal cortex transcranial direct current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite. 2011 Jun; 56(3):741-6.
    View in: PubMed
    Score: 0.005
  40. Seasonal patterns of birth for subjects with bulimia nervosa, binge eating, and purging: results from the National Women's Study. Int J Eat Disord. 2012 Jan; 45(1):131-4.
    View in: PubMed
    Score: 0.005
  41. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
    View in: PubMed
    Score: 0.005
  42. Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring). 2009 Jan; 17(1):30-9.
    View in: PubMed
    Score: 0.004
  43. The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008 Sep; 51(2):324-6.
    View in: PubMed
    Score: 0.004
  44. Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity (Silver Spring). 2007 Apr; 15(4):895-905.
    View in: PubMed
    Score: 0.004
  45. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance. Am J Drug Alcohol Abuse. 2007; 33(5):655-64.
    View in: PubMed
    Score: 0.004
  46. Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite. 2007 Mar; 48(2):145-53.
    View in: PubMed
    Score: 0.004
  47. Changes in food cravings during low-calorie and very-low-calorie diets. Obesity (Silver Spring). 2006 Jan; 14(1):115-21.
    View in: PubMed
    Score: 0.003
  48. Findings and outcomes of psychological evaluations of gastric bypass applicants. Surg Obes Relat Dis. 2005 Nov-Dec; 1(6):523-7; discussion 528-9.
    View in: PubMed
    Score: 0.003
  49. Smoking status and weight loss in three weight loss programs. Eat Behav. 2006 Jan; 7(1):61-8.
    View in: PubMed
    Score: 0.003
  50. Gender, race, and obesity-related quality of life at extreme levels of obesity. Obes Res. 2004 Jun; 12(6):949-55.
    View in: PubMed
    Score: 0.003
  51. Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
    View in: PubMed
    Score: 0.003
  52. Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
    View in: PubMed
    Score: 0.002
  53. A prospective study of holiday weight gain. N Engl J Med. 2000 Mar 23; 342(12):861-7.
    View in: PubMed
    Score: 0.002
  54. Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
    View in: PubMed
    Score: 0.002
  55. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
    View in: PubMed
    Score: 0.002
  56. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 1999 Jun; 69(6):1108-16.
    View in: PubMed
    Score: 0.002
  57. Cognitive appraisals of dietary transgressions by obese women: associations with self-reported eating behavior, depression, and actual weight loss. Int J Obes Relat Metab Disord. 1999 Mar; 23(3):231-7.
    View in: PubMed
    Score: 0.002
  58. Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation. Addict Behav. 1979; 4(2):167-77.
    View in: PubMed
    Score: 0.002
  59. Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 1997 Dec; 67(3):272-6.
    View in: PubMed
    Score: 0.002
  60. Prevalence of binge eating disorder in obese adults seeking weight loss treatment. Eat Weight Disord. 1997 Sep; 2(3):117-24.
    View in: PubMed
    Score: 0.002
  61. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
    View in: PubMed
    Score: 0.002
  62. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8.
    View in: PubMed
    Score: 0.001
  63. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry. 1990 Feb; 147(2):225-9.
    View in: PubMed
    Score: 0.001
  64. Depression and bulimia: the link between depression and bulimic cognitions. J Abnorm Psychol. 1989 Aug; 98(3):322-5.
    View in: PubMed
    Score: 0.001
  65. Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(6):893-8.
    View in: PubMed
    Score: 0.001
  66. Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
    View in: PubMed
    Score: 0.001
  67. A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
    View in: PubMed
    Score: 0.001
  68. Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
    View in: PubMed
    Score: 0.001
  69. Taste hedonics and thresholds in obesity. Int J Obes. 1980; 4(3):203-12.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.